Cargando…

Pretreatment Tumor Volume Estimation Based on Total Serum PSA in Patients with Localized Prostate Cancer

OBJECTIVES: To establish a formula that estimates tumor volume in localized prostate cancer based on serum prostate specific antigen levels. One of the main prognostic variables in localized prostate cancer is tumor volume, which can be precisely defined only after prostate extirpation. The present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Raphael Barroso, Srougi, Victor, Salvadori, Fernanda Aburesi, Ayres, Pedro Paulo Marino Rodrigues, Leite, Katia Moreira, Srougi, Miguel
Formato:	Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664275/ https://www.ncbi.nlm.nih.gov/pubmed/19060997 http://dx.doi.org/10.1590/S1807-59322008000600009

Ejemplares similares

Incidence of Histological Prostatitis and Its Correlation with PSA Density
por: Piovesan, Affonso Celso, et al.
Publicado: (2009)

Probability of Extraprostatic Disease According to the Percentage of Positive Biopsy Cores in Clinically Localized Prostate Cancer
por: Valette, Thiago N., et al.
Publicado: (2015)

Prostate Cancer Detection at Rebiopsy After an Initial Benign Diagnosis: Results Using Sextant Extended Prostate Biopsy
por: Leite, Katia Ramos Moreira, et al.
Publicado: (2008)

Detecting and grading prostate cancer in radical prostatectomy specimens through deep learning techniques
por: Melo, Petronio Augusto de Souza, et al.
Publicado: (2021)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml(−1)
por: Huang, Ma-Ping, et al.
Publicado: (2022)

The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression
por: Kawahara, Rebeca, et al.
Publicado: (2021)

PSA density of the lesion: a mathematical formula that uses clinical and pathological data to predict biochemical recurrence in prostate cancer patients
por: JUNQUEIRA, PEDRO HENRIQUE REZENDE, et al.
Publicado: (2021)

Telomere Attrition and p53 Response 1 (TAPR1): a new player in cancer biology?
por: dos Santos, Gabriel Arantes, et al.
Publicado: (2021)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions
por: Flores-Fraile, María-Carmen, et al.
Publicado: (2020)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
por: Jung, Jin-Woo, et al.
Publicado: (2019)

Usefulness of Total PSA Value in Prostate Diseases Diagnosis
por: Prcic, Alden, et al.
Publicado: (2016)

Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer
por: Reis, Sabrina T., et al.
Publicado: (2016)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer
por: Pontes-Júnior, José, et al.
Publicado: (2009)

Mean Platelet Volume Enhances the Diagnostic Specificity of PSA for Prostate Cancer
por: Song, Wei, et al.
Publicado: (2022)

Standard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: Analysis of 100 cases from a high-volume urologic center
por: Marmiroli, Rafael, et al.
Publicado: (2012)

Actual Contribution of Free to Total PSA Ratio in Prostate Diseases Differentiation
por: Prcic, Alden, et al.
Publicado: (2016)

Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men
por: Coric, Jozo, et al.
Publicado: (2015)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Can we use Ki67 expression to predict prostate cancer aggressiveness?
por: MAIA, RONALDO, et al.
Publicado: (2022)

Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population
por: Wu, Yi-Shuo, et al.
Publicado: (2018)

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
por: LIU, Xin, et al.
Publicado: (2015)

MicroRNA 100: a context dependent miRNA in prostate cancer
por: Leite, Katia R. M., et al.
Publicado: (2013)

Loss of TIMP-1 immune expression and tumor recurrence in localized prostate cancer
por: dos Reis, Sabrina Thalita, et al.
Publicado: (2015)

miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer
por: Reis, Sabrina Thalita, et al.
Publicado: (2012)

Utility of Free/Total Prostate Specific Antigen (f/t PSA) Ratio in Diagnosis of Prostate Carcinoma
por: Thakur, V., et al.
Publicado: (2004)

Seminal citrate is superior to PSA for detecting clinically significant prostate cancer
por: Gregório, Emerson Pereira, et al.
Publicado: (2019)

The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer
por: Reis, Sabrina T., et al.
Publicado: (2013)

Is The Ability to Perform Transurethral Resection of the Prostate Influenced by the Surgeon’s Previous Experience?
por: Cury, José, et al.
Publicado: (2008)

Pretreatment PSA levels affects the completion rate of Ra-223 treatment
por: Utsumi, Nobuko, et al.
Publicado: (2021)

Controlling RECK miR21 Promotes Tumor Cell Invasion and Is Related to Biochemical Recurrence in Prostate Cancer
por: Leite, Katia R. M., et al.
Publicado: (2015)

Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
por: Uçer, Oktay, et al.
Publicado: (2015)

Laparoscopic Kidney Denervation for Refractory Loin Pain: Can We Predict Outcomes?
por: Srougi, Victor, et al.
Publicado: (2016)

Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4–10 ng ml(−1)
por: Tan, Lincoln GL, et al.
Publicado: (2017)

A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer
por: Gentile, Francesco, et al.
Publicado: (2023)

Distinct urinary glycoprotein signatures in prostate cancer patients
por: Kawahara, Rebeca, et al.
Publicado: (2018)

Percutaneous radiofrequency ablation on a Xp11.2 Translocation Renal Cell Carcinoma: A case report
por: Kanas, Alexandre Fligelman, et al.
Publicado: (2020)

Comprehensive Study of Gene and microRNA Expression Related to Epithelial-Mesenchymal Transition in Prostate Cancer
por: Katz, Betina, et al.
Publicado: (2014)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_5tj5qqu80sagmbv7jbgdjt4t7l